Uncouplers and Inhibitors of Oxidative Phosphorylation

OxPhos Essentials - Powerhouse Primer

• Oxidative Phosphorylation (OxPhos): Main ATP source in aerobes.
• Location: Inner mitochondrial membrane (IMM); cristae ↑ surface area.
• Key Processes:
  • Electron Transport Chain (ETC): e⁻ from NADH/FADH₂ pass via Complexes I-IV to O₂ (forms H₂O). Pumps H⁺ to intermembrane space.
  • Chemiosmosis: ATP synthase uses H⁺ gradient (Proton Motive Force, PMF) for $ADP + P_i \rightarrow ATP$.

⭐ P:O ratio (ATP yield per electron donor): ~2.5 for NADH, ~1.5 for FADH₂.

ETC Roadblocks - Electron Jam

Inhibitors halt electron flow at specific ETC complexes, stopping ATP synthesis & $O_2$ consumption.

• Complex I (NADH Dehydrogenase):
  • Rotenone, Amytal, Piericidin A
  • Blocks $NADH \rightarrow CoQ$
• Complex II (Succinate Dehydrogenase):
  • Malonate (competes with succinate)
• Complex III (Cytochrome bc₁):
  • Antimycin A, Dimercaprol
  • Blocks $Cyt \ b \rightarrow Cyt \ c_1$
• Complex IV (Cytochrome c Oxidase): 📌 C.C.A.H.
  • Cyanide ($CN^-$), CO, Azide ($N_3^-$), $H_2S$
  • Blocks $Cyt \ a_3 \rightarrow O_2$; often lethal
• ATP Synthase ($F_o$ subunit):
  • Oligomycin
  • Blocks $H^+$ channel; ATP synthesis stops

⭐ Cyanide binds to $Fe^{3+}$ in Cytochrome Oxidase (Complex IV), preventing $O_2$ reduction and causing histotoxic hypoxia.

ATP Synthase Sabotage - Turbine Tamperers

• Directly inhibit ATP synthase (Complex V), stalling cellular energy production.
• Mechanism: Block proton flow through the F₀ subunit, halting ATP synthesis.
• Consequence: ↑ proton gradient, subsequent ETC arrest.
• Key Inhibitors:
  • Oligomycin (targets F₀)
  • Aurovertin (targets F₁)
  • DCCD (Dicyclohexylcarbodiimide) 📌 Mnemonic: "Oli's Auto DCCD stops ATP"

⭐ Oligomycin is a classic F₀ inhibitor, preventing protons from driving the ATP synthase "rotor", thus blocking ATP generation.

Uncoupling Agents - Proton Party Crashers

• Mechanism: Disrupt proton gradient by allowing H⁺ re-entry into mitochondrial matrix, bypassing ATP synthase.
• Effect: ETC & O₂ consumption ↑; ATP synthesis ↓; energy released as heat (thermogenesis).
• Examples:
  • 2,4-Dinitrophenol (DNP): Synthetic, dangerous weight-loss agent.
  • Aspirin (high doses): Salicylate toxicity.
  • Thermogenin (UCP1): Physiological, in brown adipose tissue (BAT) for heat.
  • Free Fatty Acids (FFAs): Endogenous.
• Key Outcomes: ↑O₂ use, ↓ATP, ↑Heat, ↑Basal Metabolic Rate (BMR).
• 📌 Mnemonic: "Diet Aids Try Fat-burning" (DNP, Aspirin, Thermogenin, FFAs).

⭐ Thermogenin (UCP1) in brown adipose tissue facilitates non-shivering thermogenesis, crucial for newborns and hibernating animals.

Clinical Correlations - When OxPhos Goes Wrong

• Uncoupling Agents: Disrupt H⁺ gradient; ATP synthesis ↓, O₂ use ↑, heat ↑.
  • Examples: Aspirin (overdose), 2,4-Dinitrophenol (DNP), Thermogenin (UCP1 in brown fat).
  • Clinical: Hyperthermia, tachypnea.
• ETC Inhibitors: Block electron flow; ATP synthesis ↓, O₂ use ↓.
  • Complex I: Rotenone (pesticide), Amytal (barbiturate).
  • Complex III: Antimycin A.
  • Complex IV (Cytochrome c Oxidase): Cyanide ($CN^-$), Carbon Monoxide (CO), Hydrogen Sulfide ($H_2S$), Sodium Azide.
    • $CN^-$: Almond breath, lactic acidosis. Treat: Nitrites, thiosulfate.
    • CO: Cherry-red skin, headache. Treat: 100% O₂.
  • ATP Synthase (Complex V): Oligomycin.
• OxPhos Diseases:
  • Mitochondrial myopathies (e.g., MELAS, MERRF), Leber's Hereditary Optic Neuropathy (LHON).
  • Maternally inherited.

⭐ Cyanide ($CN^-$) inhibits Complex IV (Cytochrome c oxidase), leading to rapid cellular hypoxia and severe lactic acidosis. Treatment involves nitrites and thiosulfate.

High‑Yield Points - ⚡ Biggest Takeaways

• Uncouplers (e.g., 2,4-DNP, aspirin, thermogenin) dissipate proton gradient: ↑ O₂ use, ↑ heat, ↓ ATP synthesis.
• Oligomycin inhibits ATP synthase (Complex V), blocking ATP synthesis and coupled electron flow.
• Rotenone & Amytal inhibit Complex I; Antimycin A inhibits Complex III.
• Cyanide (CN⁻), CO, Azide (N₃⁻) inhibit Complex IV (cytochrome c oxidase), halting electron flow.
• Atractyloside inhibits adenine nucleotide translocase (ANT), blocking ADP/ATP mitochondrial exchange.
• Uncoupling causes hyperthermia; ETC inhibition leads to ATP depletion & lactic acidosis.